nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—muscle cancer	0.681	1	CbGaD
Ketorolac—PTGS2—Etoposide—muscle cancer	0.105	0.542	CbGbCtD
Ketorolac—PTGS1—Etoposide—muscle cancer	0.0888	0.458	CbGbCtD
Ketorolac—Tiaprofenic acid—PTGS2—muscle cancer	0.000916	0.179	CrCbGaD
Ketorolac—Nepafenac—PTGS2—muscle cancer	0.000872	0.17	CrCbGaD
Ketorolac—Fenbufen—PTGS2—muscle cancer	0.000834	0.163	CrCbGaD
Ketorolac—Tolmetin—PTGS2—muscle cancer	0.000724	0.142	CrCbGaD
Ketorolac—Salsalate—PTGS2—muscle cancer	0.000724	0.142	CrCbGaD
Ketorolac—Suprofen—PTGS2—muscle cancer	0.000694	0.136	CrCbGaD
Ketorolac—Ketoprofen—PTGS2—muscle cancer	0.000353	0.069	CrCbGaD
Ketorolac—Discomfort—Etoposide—muscle cancer	0.000191	0.0016	CcSEcCtD
Ketorolac—Face oedema—Doxorubicin—muscle cancer	0.000189	0.00158	CcSEcCtD
Ketorolac—Hypersensitivity—Dactinomycin—muscle cancer	0.000189	0.00158	CcSEcCtD
Ketorolac—Gastrointestinal pain—Vincristine—muscle cancer	0.000187	0.00156	CcSEcCtD
Ketorolac—Confusional state—Etoposide—muscle cancer	0.000187	0.00156	CcSEcCtD
Ketorolac—Pancytopenia—Methotrexate—muscle cancer	0.000185	0.00155	CcSEcCtD
Ketorolac—Anaphylactic shock—Etoposide—muscle cancer	0.000185	0.00155	CcSEcCtD
Ketorolac—Infection—Etoposide—muscle cancer	0.000184	0.00154	CcSEcCtD
Ketorolac—Asthenia—Dactinomycin—muscle cancer	0.000184	0.00153	CcSEcCtD
Ketorolac—Blood creatinine increased—Doxorubicin—muscle cancer	0.000183	0.00153	CcSEcCtD
Ketorolac—Dysuria—Methotrexate—muscle cancer	0.000183	0.00152	CcSEcCtD
Ketorolac—Thrombocytopenia—Etoposide—muscle cancer	0.000181	0.00152	CcSEcCtD
Ketorolac—Tachycardia—Etoposide—muscle cancer	0.000181	0.00151	CcSEcCtD
Ketorolac—Body temperature increased—Vincristine—muscle cancer	0.000181	0.00151	CcSEcCtD
Ketorolac—Abdominal pain—Vincristine—muscle cancer	0.000181	0.00151	CcSEcCtD
Ketorolac—Liver function test abnormal—Doxorubicin—muscle cancer	0.000181	0.00151	CcSEcCtD
Ketorolac—Skin disorder—Etoposide—muscle cancer	0.00018	0.0015	CcSEcCtD
Ketorolac—Hyperhidrosis—Etoposide—muscle cancer	0.000179	0.0015	CcSEcCtD
Ketorolac—Abdominal pain upper—Doxorubicin—muscle cancer	0.000179	0.00149	CcSEcCtD
Ketorolac—Photosensitivity reaction—Methotrexate—muscle cancer	0.000178	0.00149	CcSEcCtD
Ketorolac—Hypokalaemia—Doxorubicin—muscle cancer	0.000178	0.00149	CcSEcCtD
Ketorolac—Breast disorder—Doxorubicin—muscle cancer	0.000177	0.00148	CcSEcCtD
Ketorolac—Anorexia—Etoposide—muscle cancer	0.000177	0.00148	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000176	0.00147	CcSEcCtD
Ketorolac—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000176	0.00147	CcSEcCtD
Ketorolac—Diarrhoea—Dactinomycin—muscle cancer	0.000175	0.00146	CcSEcCtD
Ketorolac—Pneumonia—Methotrexate—muscle cancer	0.000175	0.00146	CcSEcCtD
Ketorolac—Nasopharyngitis—Doxorubicin—muscle cancer	0.000175	0.00146	CcSEcCtD
Ketorolac—Drowsiness—Methotrexate—muscle cancer	0.000174	0.00145	CcSEcCtD
Ketorolac—Hypotension—Etoposide—muscle cancer	0.000173	0.00145	CcSEcCtD
Ketorolac—Gastritis—Doxorubicin—muscle cancer	0.000173	0.00145	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000173	0.00144	CcSEcCtD
Ketorolac—Renal failure—Methotrexate—muscle cancer	0.000171	0.00143	CcSEcCtD
Ketorolac—Abdominal distension—Doxorubicin—muscle cancer	0.00017	0.00142	CcSEcCtD
Ketorolac—Stomatitis—Methotrexate—muscle cancer	0.00017	0.00142	CcSEcCtD
Ketorolac—Conjunctivitis—Methotrexate—muscle cancer	0.000169	0.00141	CcSEcCtD
Ketorolac—Asthma—Doxorubicin—muscle cancer	0.000169	0.00141	CcSEcCtD
Ketorolac—Hypersensitivity—Vincristine—muscle cancer	0.000169	0.00141	CcSEcCtD
Ketorolac—Eosinophilia—Doxorubicin—muscle cancer	0.000167	0.0014	CcSEcCtD
Ketorolac—Sweating—Methotrexate—muscle cancer	0.000167	0.00139	CcSEcCtD
Ketorolac—Paraesthesia—Etoposide—muscle cancer	0.000166	0.00139	CcSEcCtD
Ketorolac—Haematuria—Methotrexate—muscle cancer	0.000166	0.00139	CcSEcCtD
Ketorolac—Pancreatitis—Doxorubicin—muscle cancer	0.000166	0.00138	CcSEcCtD
Ketorolac—Dyspnoea—Etoposide—muscle cancer	0.000165	0.00138	CcSEcCtD
Ketorolac—Somnolence—Etoposide—muscle cancer	0.000165	0.00138	CcSEcCtD
Ketorolac—Hepatobiliary disease—Methotrexate—muscle cancer	0.000165	0.00138	CcSEcCtD
Ketorolac—Epistaxis—Methotrexate—muscle cancer	0.000164	0.00137	CcSEcCtD
Ketorolac—Asthenia—Vincristine—muscle cancer	0.000164	0.00137	CcSEcCtD
Ketorolac—Vomiting—Dactinomycin—muscle cancer	0.000163	0.00136	CcSEcCtD
Ketorolac—Agranulocytosis—Methotrexate—muscle cancer	0.000162	0.00136	CcSEcCtD
Ketorolac—Rash—Dactinomycin—muscle cancer	0.000161	0.00135	CcSEcCtD
Ketorolac—Decreased appetite—Etoposide—muscle cancer	0.000161	0.00135	CcSEcCtD
Ketorolac—Pancytopenia—Doxorubicin—muscle cancer	0.000161	0.00134	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Etoposide—muscle cancer	0.00016	0.00134	CcSEcCtD
Ketorolac—Fatigue—Etoposide—muscle cancer	0.00016	0.00133	CcSEcCtD
Ketorolac—Pain—Etoposide—muscle cancer	0.000159	0.00132	CcSEcCtD
Ketorolac—Constipation—Etoposide—muscle cancer	0.000159	0.00132	CcSEcCtD
Ketorolac—Dysuria—Doxorubicin—muscle cancer	0.000158	0.00132	CcSEcCtD
Ketorolac—Haemoglobin—Methotrexate—muscle cancer	0.000157	0.00131	CcSEcCtD
Ketorolac—Diarrhoea—Vincristine—muscle cancer	0.000157	0.00131	CcSEcCtD
Ketorolac—Haemorrhage—Methotrexate—muscle cancer	0.000156	0.00131	CcSEcCtD
Ketorolac—Hepatitis—Methotrexate—muscle cancer	0.000156	0.00131	CcSEcCtD
Ketorolac—Pollakiuria—Doxorubicin—muscle cancer	0.000156	0.0013	CcSEcCtD
Ketorolac—Urinary tract disorder—Methotrexate—muscle cancer	0.000154	0.00129	CcSEcCtD
Ketorolac—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000154	0.00129	CcSEcCtD
Ketorolac—Weight increased—Doxorubicin—muscle cancer	0.000154	0.00129	CcSEcCtD
Ketorolac—Urethral disorder—Methotrexate—muscle cancer	0.000153	0.00128	CcSEcCtD
Ketorolac—Feeling abnormal—Etoposide—muscle cancer	0.000153	0.00128	CcSEcCtD
Ketorolac—Hyperglycaemia—Doxorubicin—muscle cancer	0.000153	0.00127	CcSEcCtD
Ketorolac—Nausea—Dactinomycin—muscle cancer	0.000152	0.00127	CcSEcCtD
Ketorolac—Pneumonia—Doxorubicin—muscle cancer	0.000152	0.00127	CcSEcCtD
Ketorolac—Gastrointestinal pain—Etoposide—muscle cancer	0.000152	0.00127	CcSEcCtD
Ketorolac—Dizziness—Vincristine—muscle cancer	0.000151	0.00126	CcSEcCtD
Ketorolac—Drowsiness—Doxorubicin—muscle cancer	0.000151	0.00126	CcSEcCtD
Ketorolac—Visual impairment—Methotrexate—muscle cancer	0.000151	0.00126	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000149	0.00125	CcSEcCtD
Ketorolac—Renal failure—Doxorubicin—muscle cancer	0.000148	0.00124	CcSEcCtD
Ketorolac—Erythema multiforme—Methotrexate—muscle cancer	0.000148	0.00123	CcSEcCtD
Ketorolac—Urticaria—Etoposide—muscle cancer	0.000147	0.00123	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—muscle cancer	0.000147	0.00123	CcSEcCtD
Ketorolac—Stomatitis—Doxorubicin—muscle cancer	0.000147	0.00123	CcSEcCtD
Ketorolac—Abdominal pain—Etoposide—muscle cancer	0.000147	0.00122	CcSEcCtD
Ketorolac—Body temperature increased—Etoposide—muscle cancer	0.000147	0.00122	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—muscle cancer	0.000147	0.00122	CcSEcCtD
Ketorolac—Eye disorder—Methotrexate—muscle cancer	0.000146	0.00122	CcSEcCtD
Ketorolac—Tinnitus—Methotrexate—muscle cancer	0.000146	0.00122	CcSEcCtD
Ketorolac—Vomiting—Vincristine—muscle cancer	0.000145	0.00122	CcSEcCtD
Ketorolac—Cardiac disorder—Methotrexate—muscle cancer	0.000145	0.00121	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—muscle cancer	0.000145	0.00121	CcSEcCtD
Ketorolac—Rash—Vincristine—muscle cancer	0.000144	0.00121	CcSEcCtD
Ketorolac—Dermatitis—Vincristine—muscle cancer	0.000144	0.0012	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—muscle cancer	0.000144	0.0012	CcSEcCtD
Ketorolac—Headache—Vincristine—muscle cancer	0.000143	0.0012	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000143	0.00119	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—muscle cancer	0.000142	0.00119	CcSEcCtD
Ketorolac—Angiopathy—Methotrexate—muscle cancer	0.000142	0.00118	CcSEcCtD
Ketorolac—Immune system disorder—Methotrexate—muscle cancer	0.000141	0.00118	CcSEcCtD
Ketorolac—Mediastinal disorder—Methotrexate—muscle cancer	0.000141	0.00118	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—muscle cancer	0.000141	0.00117	CcSEcCtD
Ketorolac—Chills—Methotrexate—muscle cancer	0.00014	0.00117	CcSEcCtD
Ketorolac—Alopecia—Methotrexate—muscle cancer	0.000138	0.00115	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—muscle cancer	0.000138	0.00115	CcSEcCtD
Ketorolac—Mental disorder—Methotrexate—muscle cancer	0.000137	0.00114	CcSEcCtD
Ketorolac—Hypersensitivity—Etoposide—muscle cancer	0.000137	0.00114	CcSEcCtD
Ketorolac—Erythema—Methotrexate—muscle cancer	0.000136	0.00114	CcSEcCtD
Ketorolac—Malnutrition—Methotrexate—muscle cancer	0.000136	0.00114	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—muscle cancer	0.000136	0.00114	CcSEcCtD
Ketorolac—Nausea—Vincristine—muscle cancer	0.000136	0.00114	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—muscle cancer	0.000136	0.00113	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—muscle cancer	0.000135	0.00113	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—muscle cancer	0.000135	0.00113	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—muscle cancer	0.000134	0.00112	CcSEcCtD
Ketorolac—Dysgeusia—Methotrexate—muscle cancer	0.000133	0.00111	CcSEcCtD
Ketorolac—Asthenia—Etoposide—muscle cancer	0.000133	0.00111	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—muscle cancer	0.000133	0.00111	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—muscle cancer	0.000133	0.00111	CcSEcCtD
Ketorolac—Back pain—Methotrexate—muscle cancer	0.000132	0.0011	CcSEcCtD
Ketorolac—Pruritus—Etoposide—muscle cancer	0.000131	0.0011	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—muscle cancer	0.00013	0.00109	CcSEcCtD
Ketorolac—Vision blurred—Methotrexate—muscle cancer	0.000128	0.00107	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—muscle cancer	0.000128	0.00107	CcSEcCtD
Ketorolac—Diarrhoea—Etoposide—muscle cancer	0.000127	0.00106	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—muscle cancer	0.000126	0.00106	CcSEcCtD
Ketorolac—Ill-defined disorder—Methotrexate—muscle cancer	0.000126	0.00105	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—muscle cancer	0.000126	0.00105	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—muscle cancer	0.000126	0.00105	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—muscle cancer	0.000126	0.00105	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—muscle cancer	0.000126	0.00105	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—muscle cancer	0.000123	0.00103	CcSEcCtD
Ketorolac—Malaise—Methotrexate—muscle cancer	0.000123	0.00102	CcSEcCtD
Ketorolac—Dizziness—Etoposide—muscle cancer	0.000123	0.00102	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—muscle cancer	0.000122	0.00102	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—muscle cancer	0.000122	0.00102	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—muscle cancer	0.000122	0.00102	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—muscle cancer	0.000122	0.00102	CcSEcCtD
Ketorolac—Chills—Doxorubicin—muscle cancer	0.000121	0.00101	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—muscle cancer	0.000121	0.00101	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—muscle cancer	0.00012	0.000999	CcSEcCtD
Ketorolac—Cough—Methotrexate—muscle cancer	0.000119	0.000992	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—muscle cancer	0.000119	0.00099	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—muscle cancer	0.000118	0.000984	CcSEcCtD
Ketorolac—Vomiting—Etoposide—muscle cancer	0.000118	0.000984	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—muscle cancer	0.000118	0.000984	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—muscle cancer	0.000118	0.000984	CcSEcCtD
Ketorolac—Rash—Etoposide—muscle cancer	0.000117	0.000976	CcSEcCtD
Ketorolac—Dermatitis—Etoposide—muscle cancer	0.000117	0.000975	CcSEcCtD
Ketorolac—Headache—Etoposide—muscle cancer	0.000116	0.00097	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—muscle cancer	0.000116	0.000969	CcSEcCtD
Ketorolac—Myalgia—Methotrexate—muscle cancer	0.000116	0.000967	CcSEcCtD
Ketorolac—Arthralgia—Methotrexate—muscle cancer	0.000116	0.000967	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—muscle cancer	0.000116	0.000967	CcSEcCtD
Ketorolac—Tension—Doxorubicin—muscle cancer	0.000116	0.000965	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—muscle cancer	0.000115	0.000963	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000115	0.000961	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—muscle cancer	0.000114	0.000956	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—muscle cancer	0.000114	0.000956	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—muscle cancer	0.000114	0.000952	CcSEcCtD
Ketorolac—Confusional state—Methotrexate—muscle cancer	0.000112	0.000935	CcSEcCtD
Ketorolac—Anaphylactic shock—Methotrexate—muscle cancer	0.000111	0.000927	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—muscle cancer	0.000111	0.000927	CcSEcCtD
Ketorolac—Infection—Methotrexate—muscle cancer	0.00011	0.000921	CcSEcCtD
Ketorolac—Nausea—Etoposide—muscle cancer	0.00011	0.00092	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—muscle cancer	0.000109	0.000913	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—muscle cancer	0.000109	0.000909	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—muscle cancer	0.000109	0.000909	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—muscle cancer	0.000109	0.000908	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—muscle cancer	0.000108	0.000904	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—muscle cancer	0.000108	0.000901	CcSEcCtD
Ketorolac—Hyperhidrosis—Methotrexate—muscle cancer	0.000107	0.000896	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—muscle cancer	0.000106	0.000887	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—muscle cancer	0.000106	0.000884	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—muscle cancer	0.000106	0.000884	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—muscle cancer	0.000106	0.000882	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—muscle cancer	0.000105	0.000881	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—muscle cancer	0.000104	0.000869	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—muscle cancer	0.000104	0.000867	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—muscle cancer	0.000104	0.000865	CcSEcCtD
Ketorolac—Cough—Doxorubicin—muscle cancer	0.000103	0.000859	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—muscle cancer	0.000102	0.000852	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—muscle cancer	0.000102	0.000849	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000101	0.000845	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—muscle cancer	0.0001	0.000839	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—muscle cancer	0.0001	0.000838	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—muscle cancer	0.0001	0.000838	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—muscle cancer	0.0001	0.000838	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—muscle cancer	9.99e-05	0.000835	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—muscle cancer	9.97e-05	0.000833	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	9.96e-05	0.000832	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—muscle cancer	9.91e-05	0.000828	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—muscle cancer	9.9e-05	0.000827	CcSEcCtD
Ketorolac—Somnolence—Methotrexate—muscle cancer	9.87e-05	0.000824	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—muscle cancer	9.81e-05	0.000819	CcSEcCtD
Ketorolac—Dyspepsia—Methotrexate—muscle cancer	9.77e-05	0.000816	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—muscle cancer	9.69e-05	0.00081	CcSEcCtD
Ketorolac—Decreased appetite—Methotrexate—muscle cancer	9.65e-05	0.000806	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—muscle cancer	9.61e-05	0.000803	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—muscle cancer	9.61e-05	0.000803	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—muscle cancer	9.59e-05	0.000801	CcSEcCtD
Ketorolac—Fatigue—Methotrexate—muscle cancer	9.57e-05	0.000799	CcSEcCtD
Ketorolac—Infection—Doxorubicin—muscle cancer	9.55e-05	0.000798	CcSEcCtD
Ketorolac—Pain—Methotrexate—muscle cancer	9.49e-05	0.000793	CcSEcCtD
Ketorolac—Shock—Doxorubicin—muscle cancer	9.46e-05	0.00079	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—muscle cancer	9.43e-05	0.000787	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—muscle cancer	9.41e-05	0.000786	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—muscle cancer	9.38e-05	0.000784	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—muscle cancer	9.34e-05	0.00078	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—muscle cancer	9.29e-05	0.000776	CcSEcCtD
Ketorolac—Anorexia—Doxorubicin—muscle cancer	9.16e-05	0.000765	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—muscle cancer	9.15e-05	0.000764	CcSEcCtD
Ketorolac—Gastrointestinal pain—Methotrexate—muscle cancer	9.08e-05	0.000758	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—muscle cancer	8.98e-05	0.00075	CcSEcCtD
Ketorolac—Urticaria—Methotrexate—muscle cancer	8.82e-05	0.000737	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—muscle cancer	8.78e-05	0.000733	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—muscle cancer	8.78e-05	0.000733	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—muscle cancer	8.76e-05	0.000732	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—muscle cancer	8.7e-05	0.000726	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—muscle cancer	8.63e-05	0.000721	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—muscle cancer	8.57e-05	0.000716	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—muscle cancer	8.55e-05	0.000714	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—muscle cancer	8.46e-05	0.000707	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—muscle cancer	8.36e-05	0.000698	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—muscle cancer	8.3e-05	0.000693	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—muscle cancer	8.29e-05	0.000692	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—muscle cancer	8.22e-05	0.000687	CcSEcCtD
Ketorolac—Pain—Doxorubicin—muscle cancer	8.22e-05	0.000687	CcSEcCtD
Ketorolac—Hypersensitivity—Methotrexate—muscle cancer	8.18e-05	0.000683	CcSEcCtD
Ketorolac—Asthenia—Methotrexate—muscle cancer	7.97e-05	0.000665	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—muscle cancer	7.92e-05	0.000662	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—muscle cancer	7.86e-05	0.000657	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—muscle cancer	7.86e-05	0.000656	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—muscle cancer	7.64e-05	0.000638	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—muscle cancer	7.6e-05	0.000635	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—muscle cancer	7.6e-05	0.000635	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—muscle cancer	7.6e-05	0.000634	CcSEcCtD
Ketorolac—Dizziness—Methotrexate—muscle cancer	7.34e-05	0.000613	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—muscle cancer	7.08e-05	0.000592	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—muscle cancer	7.06e-05	0.00059	CcSEcCtD
Ketorolac—Rash—Methotrexate—muscle cancer	7e-05	0.000585	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—muscle cancer	6.99e-05	0.000584	CcSEcCtD
Ketorolac—Headache—Methotrexate—muscle cancer	6.96e-05	0.000581	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—muscle cancer	6.9e-05	0.000576	CcSEcCtD
Ketorolac—Pruritus—Doxorubicin—muscle cancer	6.8e-05	0.000568	CcSEcCtD
Ketorolac—Nausea—Methotrexate—muscle cancer	6.6e-05	0.000551	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—muscle cancer	6.58e-05	0.000549	CcSEcCtD
Ketorolac—Dizziness—Doxorubicin—muscle cancer	6.36e-05	0.000531	CcSEcCtD
Ketorolac—Vomiting—Doxorubicin—muscle cancer	6.11e-05	0.000511	CcSEcCtD
Ketorolac—Rash—Doxorubicin—muscle cancer	6.06e-05	0.000506	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—muscle cancer	6.06e-05	0.000506	CcSEcCtD
Ketorolac—Headache—Doxorubicin—muscle cancer	6.02e-05	0.000503	CcSEcCtD
Ketorolac—Nausea—Doxorubicin—muscle cancer	5.71e-05	0.000477	CcSEcCtD
